Responses
ePoster Viewing
AS04. Endometrial/Uterine corpus cancers
EP113/#220 Compound AC1Q3QWB upregulates CDKN1A and SOX17 via interrupting the hotair-EZH2 interaction and enhances the efficacy of tazemetostat in endometrial cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.